SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 94 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $37,714,000 | -20.7% | 5,042,009 | +15.1% | 0.18% | -31.5% |
Q4 2020 | $47,545,000 | +31.1% | 4,381,992 | +4.8% | 0.27% | -15.9% |
Q3 2020 | $36,261,000 | -6.8% | 4,182,346 | -11.3% | 0.32% | -36.9% |
Q2 2020 | $38,887,000 | -33.4% | 4,713,594 | -52.1% | 0.51% | -7.1% |
Q1 2020 | $58,412,000 | +69.9% | 9,850,412 | +98.0% | 0.55% | +1.3% |
Q4 2019 | $34,375,000 | -28.5% | 4,974,662 | +7.4% | 0.54% | -36.7% |
Q3 2019 | $48,099,000 | +73.8% | 4,633,773 | +55.1% | 0.86% | +57.5% |
Q2 2019 | $27,667,000 | +342.2% | 2,987,763 | +336.5% | 0.54% | +229.1% |
Q1 2019 | $6,256,000 | +56772.7% | 684,475 | +33768.1% | 0.16% | – |
Q4 2018 | $11,000 | -56.0% | 2,021 | -1.4% | 0.00% | -100.0% |
Q3 2018 | $25,000 | – | 2,050 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 3,439,895 | $18,747,000 | 4.66% |
Bain Capital Life Sciences Investors, LLC | 5,785,036 | $31,528,000 | 2.07% |
Omega Fund Management, LLC | 2,274,831 | $12,398,000 | 1.40% |
Altium Capital Management LP | 1,076,942 | $5,869,000 | 1.36% |
Samsara BioCapital, LLC | 2,189,199 | $10,599,000 | 1.31% |
Sio Capital Management, LLC | 800,000 | $4,360,000 | 1.08% |
Flagship Pioneering Inc. | 2,938,494 | $16,015,000 | 0.20% |
EcoR1 Capital, LLC | 1,000,000 | $5,450,000 | 0.20% |
Artal Group S.A. | 1,700,000 | $9,265,000 | 0.19% |
ACT CAPITAL MANAGEMENT, LLC | 52,500 | $287,000 | 0.15% |